GlaxoSmithKline annual Total CO2e Emissions - Location-Based Scope 1 + Scope 2 from 2016 to 2020 (in kilotonnes)

1,280 Kt

Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020

GlaxoSmithKline Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for 12M ended Dec'20 declined to 1,280 Kt (-59 /-4.4% y-o-y). Year-over-year, it decreased to 1,280 Kt (-59 /-4.4% y-o-y). The decline accelerated compared to the CAGR of -3.4% since 4Q'16.

Full time series as generated by EXERICA AI (5 data points have been found in 2 reports from 2016 to 2020)

Date	Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for 12M ( Kt)	Total CO2e Emissions - Location-Based Scope 1 + Scope 2 as reported
Dec 2020	1,280	773 + 507
Dec 2019	1,339	795 + 544
Dec 2018	1,374	825 + 549
Dec 2017	1,497	892 + 605
Dec 2016	1,525	888 + 637